Travere Therapeutics
TVTX
TVTX
114 hedge funds and large institutions have $753M invested in Travere Therapeutics in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 48 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 121 → 114 (-7)
19% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 48
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
114
Holding in Top 10
4
Calls
$7.43M
Puts
$1.15M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$14.7M | |
| 3 | +$10.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.89M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$7.78M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$7.83M | |
| 3 | -$6.96M | |
| 4 |
Jennison Associates
New York
|
-$5.3M |
| 5 |
Millennium Management
New York
|
-$4.58M |